Nasdaq

Myriad Genetics Study Finds GeneSight Test Reduces Psychiatric Hospitalizations in Major Depressive Disorder Patients

Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Healio

Major depressive disorder linked to worse asthma outcomes among older adults

Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...
Seeking Alpha

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health ...
News Medical

Why early- and late-onset depression are fundamentally different

Study: Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depression. Image credit: Bits And Splits/Shutterstock.com Major depressive disorder (MDD ...
The American Journal of Managed Care

Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder

Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved ...